Investing.com - Liminal BioSciences (NASDAQ:LMNL) Inc reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Liminal BioSciences Inc announced earnings per share of C$-0.150 on revenue of C$3K. Analysts polled by Investing.com anticipated EPS of C$-0.140 on revenue of C$1.09M.
Liminal BioSciences Inc shares are down 29.95% from the beginning of the year, still down 70.50% from its 52 week high of C$1.68 set on November 10, 2021.
Liminal BioSciences Inc follows other major Healthcare sector earnings this month
Liminal BioSciences Inc's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of C$5.79 on revenue of C$80.89B, compared to forecasts EPS of C$5.43 on revenue of C$80.52B.
J&J had beat expectations on October 18 with third quarter EPS of C$2.55 on revenue of C$23.79B, compared to forecast for EPS of C$2.52 on revenue of C$23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar